Home / Uncategorized / FDA backs controversial drug Vytorin for kidney patients

FDA backs controversial drug Vytorin for kidney patients

$2-billion-a-year drug – which combines drugs Zocor, Zetia – already cleared to reduce bad cholesterol

Read more:
FDA backs controversial drug Vytorin for kidney patients

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top